Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
Clinical trial NCT03674047 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03674047
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2022-12-02
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.